Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Strength Cond Res. 2021 Jan 1;35(1):124–131. doi: 10.1519/JSC.0000000000002560

Table 1.

Characteristics of each trial (Mean ± SD). Values are reported as adjusted means when covaried for salivary estradiol.

PLA LMW HMW
Ride-to-Exhaustion
 Distance (km) 22.0 ± 3.0 23.4 ± 2.9 21.5 ± 3.0
 Time (min) 98.3 ± 11.4 103.2 ± 10.3 92.3 ± 10.2
 Initial RER (L/L) 0.88 ± 0.05 0.89 ± 0.04 0.89 ± 0.04
 Final RER (L/L) 0.83 ± 0.03 0.83 ± 0.04 0.83 ± 0.03
Time Trial
 Power (watts) 161.4 ± 21.8 161.7 ± 21.6 164.5 ± 21.4
 Distance (km) 7.5 ± 1.1 6.8 ± 1.8 7.1 ± 1.1
 RER (L/L) 0.88 ± 0.03* 0.92 ± 0.03 0.93 ± 0.04
Resting Recovery
 RER (L/L) 0.70 ± 0.03 0.71 ± 0.04 0.72 ± 0.02
Hormonal Status
 Salivary Estradiol (pg/mL) 1.82 ± 0.64 1.45 ± 0.39 1.55 ± 0.61
Hydration Status
 TBW (ΔL) −0.67 ± 0.60 −0.53 ± 0.58 −0.63 ± 0.52
*

indicates significant difference between treatments (p<0.05); Δ = change